Stock Scorecard



Stock Summary for InMed Pharmaceuticals Inc (INM) - $0.36 as of 3/28/2024 10:26:59 PM EST

Total Score

17 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for INM

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for INM

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for INM

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for INM

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for INM

InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying - Beneficient ( NASDAQ:BENF ) , Geovax Labs ( NASDAQ:GOVX ) 2/23/2024 12:34:00 PM
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying - Charles & Colvard ( NASDAQ:CTHR ) , Cosmos Health ( NASDAQ:COSM ) 2/22/2024 1:51:00 PM
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need - InMed Pharmaceuticals ( NASDAQ:INM ) 1/25/2024 1:15:00 PM
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket - Aurora Tech ( NASDAQ:ATAK ) , Aclarion ( NASDAQ:ACON ) 12/21/2023 12:46:00 PM
InMed's ( NASDAQ: INM ) Latest Research Demonstrates Potential In Treating Alzheimer's with a Rare Cannabinoid Analog - InMed Pharmaceuticals ( NASDAQ:INM ) 12/11/2023 1:22:00 PM
A short seller with a 95% win ratio shares 5 stocks he recently traded and why his strategy of finding cash-strapped companies to bet against is working better than ever 11/4/2023 8:00:00 AM
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Ascent Solar Technologies ( NASDAQ:ASTI ) , Alphatec Holdings ( NASDAQ:ATEC ) 10/25/2023 12:03:00 PM
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations - InMed Pharmaceuticals ( NASDAQ:INM ) , Agilysys ( NASDAQ:AGYS ) 10/24/2023 6:34:00 PM
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings - General Motors ( NYSE:GM ) , Ascent Solar Technologies ( NASDAQ:ASTI ) 10/24/2023 4:59:00 PM
Pharma Stock News - InMed Pharmaceuticals Inc.'s ( NASDAQ: INM ) INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in Preclinical Proof-of-Concept Studies 10/24/2023 2:50:00 PM

Financial Details for INM

Company Overview

Ticker INM
Company Name InMed Pharmaceuticals Inc
Country USA
Description InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/13/2024

Stock Price History

Last Day Price 0.36
Last Day Price Updated 3/28/2024 10:26:59 PM EST
Last Day Volume 59,806
Average Daily Volume 221,524
52-Week High 1.65
52-Week Low 0.29
Last Price to 52 Week Low 24.14%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -0.84
Free Cash Flow Ratio 0.23
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 7.03
Total Cash Per Share 1.57
Book Value Per Share Most Recent Quarter 2.25
Price to Book Ratio 0.17
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.41
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 6,059,000
Market Capitalization 2,181,240
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 3.57%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 57.27%
Reported EPS 12 Trailing Months -0.42
Reported EPS Past Year -0.29
Reported EPS Prior Year -8.82
Net Income Twelve Trailing Months -6,351,348
Net Income Past Year -7,947,622
Net Income Prior Year -18,600,117
Quarterly Revenue Growth YOY 164.00%
5-Year Revenue Growth 623.65%

Balance Sheet

Total Cash Most Recent Quarter 9,500,000
Total Cash Past Year 8,956,939
Total Cash Prior Year 6,221,670
Net Cash Position Most Recent Quarter 9,500,000
Net Cash Position Past Year 8,956,939
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 12,089,727
Total Stockholder Equity Prior Year 9,078,541
Total Stockholder Equity Most Recent Quarter 12,772,211

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.01
MACD Signal 0.00
20-Day Bollinger Lower Band 0.32
20-Day Bollinger Middle Band 0.38
20-Day Bollinger Upper Band 0.44
Beta 0.46
RSI 43.97
50-Day SMA 0.74
200-Day SMA 2.28

System

Modified 3/28/2024 10:27:45 PM EST